References
- Brady KT, Lydiard RB, Malcolm R, Ballenger JC.. Cocaine-induced psychosis. J Clin Psychiatry. 1991; 52: 509–512. [PUBMED], [INFOTRIEVE]
- MMWR. Increasing morbidity and mortality associated with abuse of methamphetamine—United States. 1991-1994, MMWR Morb Mortal Wkly Rpt. 1995; 44: 882–886
- Derlet RW, Rice P, Horowitz BZ, Lord RV.. Amphetamine toxicity: experience with 127 cases. J Emerg Med. 1989; 7: 157–161. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Rockwell DA, Ostwald P.. Amphetamine use and abuse in psychiatric patients. Arch Gen Psychiatry. 1968; 18: 612–616. [PUBMED], [INFOTRIEVE]
- Angrist BM, Sathananthan G, Wilk S, Gershon S.. Amphetamine psychosis: behavioral and biochemical aspects. J Psychiatr Res. 1974; 11: 13–23. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Angrist BM, Gershon S.. The phenomenology of experimentally induced amphetamine psychosis—preliminary observations. Biol Psychiatry. 1970; 2: 95–107. [PUBMED], [INFOTRIEVE]
- Griffith JD, Oates J, Cavanaugh J.. Paranoid episodes induced by drug. JAMA. 1968; 205: 39
- Bell DS.. A comparison of amphetamine psychosis and schizophrenia. Br J Psychiatry. 1965; 3: 701
- Janowsky DS, Davis JM.. Methylphenidate, dextroamphetamine, and levamphetamine: effects on schizophrenic symptoms. Arch Gen Psychiatry. 1976; 33: 304–308. [PUBMED], [INFOTRIEVE]
- Angrist BM, Rotrosen J, Gershon S.. Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia. Psychopharmacology (Berl). 1980; 72: 17–19. [CROSSREF]
- Laruelle M, Abi-Dargham A, van Dyck CH, et al, Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci USA. 1996; 93: 9235–9240
- McLellan AT, Woody GE. O'Brien CP. Development of psychiatric illness in drug abusers: possible role of drug preference. N Engl J Med. 1979; 301: 1310–1314
- Sato M, Chen CC, Akiyama K, Otsuki S.. Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis. Biol Psychiatry. 1983; 18: 429–440. [PUBMED], [INFOTRIEVE]
- Flaum M, Schultz SK.. When does amphetamine-induced psychosis become schizophrenia?. Am J Psychiatry. 1996; 153: 812–815. [PUBMED], [INFOTRIEVE]
- Sherer MA, Kumor KM, Cone EJ, Jaffe JH.. Suspiciousness induced by four-hour intravenous infusions of cocaine: preliminary findings. Arch Gen Psychiatry. 1988; 45: 673–677. [PUBMED], [INFOTRIEVE]
- Ujike H.. Stimulant-induced psychosis and schizophrenia: the role of sensitization. Curr Psychiatry Rep. 2002; 4: 177–184. [PUBMED], [INFOTRIEVE], [CSA]
- Laruelle M.. The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies. Brain Res Rev. 2000; 31: 371–384. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Snyder SH.. Catecholamines in the brain as mediators of amphetamine psychosis. Arch Gen Psychiatry. 1972; 27: 169–179. [PUBMED], [INFOTRIEVE]
- Lieberman JA, Kinon BJ, Loebel AD.. Dopaminergic mechanisms in idiopathic and drug-induced psychoses. Schizophr Bull. 1990; 16: 97–110. [PUBMED], [INFOTRIEVE]
- Sato M.. A lasting vulnerability to psychosis in patients with previous methamphetamine psychosis. Ann NY Acad Sci. 1992; 654: 160–170. [PUBMED], [INFOTRIEVE]
- Siomopoulos V.. Amphetamine psychosis: overview and a hypothesis. Dis Nerv Syst. 1975; 36: 336–339. [PUBMED], [INFOTRIEVE]
- Robinson TE, Jurson PA, Bennett JA, Bentgen KM.. Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)−amphetamine: a microdialysis study in freely moving rats. Brain Res. 1988; 462: 211–222. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Breier A, Su TP, Saunders R, et al, Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc Natl Acad Sci USA. 1997; 94: 2569–2574. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Post RM.. Cocaine psychoses: a continuum model. Am J Psychiatry. 1975; 132: 225–231. [PUBMED], [INFOTRIEVE]
- Yui K, Goto K, Ikemoto S, Nishijima K, Yoshino T, Ishiguro T.. Susceptibility to subsequent episodes of spontaneous recurrence of methamphetamine psychosis. Drug Alcohol Depend. 2001; 64: 133–142. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kirch D, Hattox S, Bell J, Murphy R, Freedman R.. Plasma homovanillic acid and tardive dyskinesia during neuroleptic maintenance and withdrawal. Psychiatry Res. 1983; 9: 217–223. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Daras M, Koppel BS, Atos-Radzion E.. Cocaine-induced choreoathetoid movements (‘crack dancing’). Neurology. 1994; 44: 751–752. [PUBMED], [INFOTRIEVE]
- Levy AD, Ellison GD.. Interaction between chronic amphetamine and neuroleptic treatments on oral behavior in rats. Psychopharmacology (Berl). 1987; 93: 218–222
- Lloyd KG, Willigens MT, Goldstein M.. Induction and reversal of dopamine dyskinesia in rat, cat, and monkey. Psychopharmacology Suppl. 1985; 2: 200–210. [PUBMED], [INFOTRIEVE]
- Mercuri NB, Calabresi P, Bernardi G.. The electrophysiological actions of dopamine and dopaminergic drugs on neurons of the substantia nigra pars compacta and ventral tegmental area. Life Sci. 1992; 51: 711–718. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Harris D, Batki SL.. Stimulant psychosis: symptom profile and acute clinical course. Am J Addict. 2000; 9: 28–37. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Batki SL, Manfredi LB, Jacob P, III, Jones RT.. Fluoxetine for cocaine dependence in methadone maintenance: quantitative plasma and urine cocaine/benzoylecgonine concentrations. J Clin Psychopharmacol. 1993; 13: 243–250. [PUBMED], [INFOTRIEVE]
- Gawin FH, Kleber HD.. Cocaine abuse treatment: open pilot trial with desipramine and lithium carbonate. Arch Gen Psychiatry. 1984; 41: 903–909. [PUBMED], [INFOTRIEVE]
- First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders. New York, NY, New York State Psychiatric Institute, Biometrics Research Department;. 1995
- Kay SR, Fiszbein A, Opler LA.. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987; 13: 261–276. [PUBMED], [INFOTRIEVE]
- Overall JE, Gorham DE.. The Brief Psychiatric Rating Scale. Psychol Rep. 1962; 10: 799–812
- Gerlach J, Korsgaard S, Clemmesen P, et al, The St. Hans Rating Scale for extrapyramidal syndromes: reliability and validity. Acta Psychiatr Scand. 1993; 87: 244–252. [PUBMED], [INFOTRIEVE]
- Van Kammen DP, Marder SR.. Dopamine receptor antagonists. Kaplan HI, Sadock BJ. Comprehensive Textbook of Psychiatry/VI. Baltimore, MD, Williams & Wilkins. 1995:1989
- Hayashi T, Tadokoro S.. Parallelism between avoidance-suppressing and prolactin-increasing effects of antipsychotic drugs in rats. Jpn J Pharmacol. 1984; 35: 451–456. [PUBMED], [INFOTRIEVE], [CSA]
- Ciraulo DA, Greenblatt DJ.. Sedative-, hypnotic-, or anxiolytic-related disorders. Kaplan HI, Sadock BJ. Comprehensive Textbook of Psychiatry/VI. Baltimore, MD, Williams & Wilkins. 1995:884
- Kay SR.. Positive and Negative Syndromes in Schizophrenia: Assessment and Research. Vol. 5, New York, Brunner/Mazel, Inc.. 1991
- Batki SL, Moon J, Delucchi K, et al, Methamphetamine quantitative urine concentrations during a controlled trial of fluoxetine treatment: preliminary analysis. Ann NY Acad Sci.. 2000; 909: 260–263. [PUBMED], [INFOTRIEVE], [CSA]
- Serper MR, Alpert M, Richardson NA, Dickson S, Allen MH, Werner A.. Clinical effects of recent cocaine use on patients with acute schizophrenia. Am J Psychiatry. 1995; 152: 1464–1469. [PUBMED], [INFOTRIEVE]
- Pezze MA, Feldon J, Murphy CA.. Increased conditioned fear response and altered balance of dopamine in the shell and core of the nucleus accumbens during amphetamine withdrawal. Neuropharmacology. 2002; 42: 633–643. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lieberman JA, Sheitman BB, Kinon BJ.. Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity. Neuropsychopharmacology. 1997; 17: 205–229. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]